Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Allergy|August 2, 2025
Fungal-Driven Airways Dis-Immunity From Asthma to Allergic Bronchopulmonary Aspergillosis: Dissecting Similarities and DifferencesMarco Caminati, Isabella Annesi-Maesano, Wojciech Feleszko, et al.
Expert Review of Respiratory Medicine|December 13, 2025
When hypereosinophilia occurs during dupilumab therapy: evidence-based strategies for clinical management in respiratory indicationsMarco Caminati, Andrea Portacci, Francesca Cefaloni, et al.
Biomedicines|March 28, 2026
Trends of T2 and Non-T2 Cytokines During Mepolizumab Treatment in Different Asthma Patient SubgroupsMarco Zurlo, Francesca Ambrosani, Matteo Maule, et al.
The World Allergy Organization Journal|August 23, 2024
Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohortMarco Caminati, Alessandro Marcon, Rachele Vaia, et al.
Vaccines|December 28, 2021
Current Take on Systemic Sclerosis Patients' Vaccination RecommendationsGiuseppe Murdaca, Giovanni Noberasco, Dario Olobardi, et al.
Biomedicines|February 24, 2024
Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life PerspectiveMarco Caminati, Matteo Maule, Roberto Benoni, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 16, 2025
Profiling Blood Hypereosinophilia in Patients on Dupilumab Treatment for Respiratory Conditions: A Real-Life SnapshotMarco Caminati, Matteo Maule, Diego Bagnasco, et al.
Respiratory Medicine|June 13, 2025
ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-upLaura Pini, Marco Caminati, Matteo Maule, et al.
Journal of Clinical Medicine|May 25, 2024
Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life StudyLaura Pini, Diego Bagnasco, Bianca Beghè, et al.
Cells|July 26, 2024
Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC)Marco Caminati, Luisa Brussino, Matilde Carlucci, et al.
Pageof 3